Revlimid (lenalidomide) is a brand-name oral capsule that’s prescribed for certain types of myeloma, lymphoma, and anemia. As with other drugs, Revlimid can cause side effects, such as skin rash and ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. WARNING: Important safety information is provided in a boxed warning ...

Revlimid (lenalidomide) is a brand-name drug that doctors may prescribe to treat certain cancers of the blood. If a person has a Medicare Part D prescription drug plan or a Medicare Advantage (Part C) ...

The FDA notified the public of an increased risk of second primary malignancies in patients with newly-diagnosed multiple myeloma who received Revlimid (lenalidomide capsules; Celgene). This update is ...

Lupin has received approval from the Food and Drug Administration for lenalidomide capsules, 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg, which are the generic of Bristol-Myers Squibb's Revlimid. The ...

Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide — brand name Revlimid — to ...

BOSTON, Dec 1 (Reuters) - Sales of Celgene Corp's cancer drug Revlimid could rise by more than a third if data due to be presented next Monday at the annual meeting of the American Society of ...

BOSTON, Dec 7 (Reuters) - Celgene Corp said on Monday that a trial of its cancer drug Revlimid showed it reduced the risk of disease progression in newly diagnosed patients with multiple myeloma by 50 ...

[Read more: Amneal rolls out Crexont] Additionally, Amneal has received approval from the Food and Drug Administration for lenalidomide capsules in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg ...

Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...